Literature DB >> 29770752

Ventilator Bundle Compliance and Risk of Ventilator-Associated Events.

Bryan D Harris1, Gale A Thomas1, Matthew H Greene1, Steven S Spires1, Thomas R Talbot1.   

Abstract

OBJECTIVEVentilator bundles encompass practices that reduce the risk of ventilator complications, including ventilator-associated pneumonia. The impact of ventilator bundles on the risk of developing ventilator-associated events (VAEs) is unknown. We sought to determine whether decreased compliance to the ventilator bundle increases the risk for VAE development.DESIGNNested case-control study.SETTINGThis study was conducted at 6 adult intensive care units at an academic tertiary-care center in Tennessee.PATIENTSIn total, 273 patients with VAEs were randomly matched in a 1:4 ratio to controls by mechanical ventilation duration and ICU type.METHODSControls were selected from the primary study population at risk for a VAE after being mechanically ventilated for the same number of days as a specified case. Using conditional logistic regression analysis, overall cumulative compliance, and compliance with individual components of the bundle in the 3 and 7 days prior to VAE development (or the control match day) were examined.RESULTSOverall bundle compliance at 3 days (odds ratio [OR], 1.15; P=.34) and 7 days prior to VAE diagnosis (OR, 0.96; P=.83) were not associated with VAE development. This finding did not change when limiting the outcome to infection-related ventilator-associated complications (IVACs) and after adjusting for age and gender. In the examination of compliance with specific bundle components increased compliance with chlorhexidine oral care was associated with increased risk of VAE development in all analyses.CONCLUSIONSVentilator bundle compliance was not associated with a reduced risk for VAEs. Higher compliance with chlorhexidine oral care was associated with a greater risk for VAE development.Infect Control Hosp Epidemiol 2018;39:637-643.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29770752     DOI: 10.1017/ice.2018.30

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  9 in total

1.  Ventilator-associated pneumonia prevention in the Intensive care unit using Postpyloric tube feeding in China (VIP study): study protocol for a randomized controlled trial.

Authors:  Linhui Hu; Kaiyi Peng; Xiangwei Huang; Zheng Wang; Quanzhong Wu; Yumei Xiao; Yating Hou; Yuemei He; Xinjuan Zhou; Chunbo Chen
Journal:  Trials       Date:  2022-06-09       Impact factor: 2.728

2.  Management of Ventilator-Associated Pneumonia: Quality Assessment of Clinical Practice Guidelines and Variations in Recommendations on Drug Therapy for Prevention and Treatment.

Authors:  Hong-Yan Li; Hai-Shan Wang; Ying-Lin Wang; Jing Wang; Xue-Chen Huo; Quan Zhao
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

3.  Risk factors and associated outcomes of ventilator-associated events developed in 28 days among sepsis patients admitted to intensive care unit.

Authors:  Wen-Feng Fang; Ying-Tang Fang; Chi-Han Huang; Yu-Mu Chen; Ya-Chun Chang; Chiung-Yu Lin; Kai-Yin Hung; Ya-Ting Chang; Hung-Cheng Chen; Kuo-Tung Huang; Huang-Chih Chang; Yun-Che Chen; Yi-Hsi Wang; Chin-Chou Wang; Meng-Chih Lin
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

4.  The epidemiology and clinical outcomes of ventilator-associated events among 20,769 mechanically ventilated patients at intensive care units: an observational study.

Authors:  Zhiyong Zong; Xin Sun; Qiao He; Wen Wang; Shichao Zhu; Mingqi Wang; Yan Kang; Rui Zhang; Kang Zou
Journal:  Crit Care       Date:  2021-02-02       Impact factor: 9.097

5.  Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Siripen Kanchanasuwan; Narongdet Kositpantawong; Kamonnut Singkhamanan; Thanaporn Hortiwakul; Boonsri Charoenmak; Nwabor Ozioma F; Yohei Doi; Sarunyou Chusri
Journal:  Infect Drug Resist       Date:  2021-03-29       Impact factor: 4.003

6.  Clinical Benefits From Administering Probiotics to Mechanical Ventilated Patients in Intensive Care Unit: A PRISMA-Guided Meta-Analysis.

Authors:  Hongzhuan Song; Wenqing Hu; Xiujie Zhou; Jiaping Tao; Siyi Zhang; Xuhong Su; Wenjun Wu
Journal:  Front Nutr       Date:  2022-01-27

7.  Relationship between ventilator bundle compliance and the occurrence of ventilator-associated events: a prospective cohort study.

Authors:  Eman Arafa Hassan; Suad Elsayed Abdelmotalb Elsaman
Journal:  BMC Nurs       Date:  2022-08-01

8.  Associations Between Antithrombosis and Ventilator-Associated Events, ICU Stays, and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study.

Authors:  Mingqi Wang; Wen Wang; Xue Jia; Qiao He; Shichao Zhu; Yan Kang; Rui Zhang; Yan Ren; Ling Li; Kang Zou; Zhiyong Zong; Xin Sun
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

Review 9.  Ventilator-associated pneumonia in adults: a narrative review.

Authors:  Laurent Papazian; Michael Klompas; Charles-Edouard Luyt
Journal:  Intensive Care Med       Date:  2020-03-10       Impact factor: 17.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.